Shop
-1.png)
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 29 2025
JAMA Dermatology has recently published the results of a retrospective cohort study evaluating the efficacy of supplementation with nicotinamide, vita...
The use of continuous glucose monitoring (CGM) among people with insulin-dependent diabetes has gained wider acceptance, as it has shown benefit in controlling glucose even among those receiving only basal insulin. However, CGM use among non-insulin dependent diabetics, and especially among those with prediabetes or even healthy adults, is not well-established.
In the Sugar Challenge Study, a recent observational study with 665 participants, the use of CGM combined with a mobile app (Sugar AI) providing feedback was evaluated over a 10-day period. A broad range of participants was enrolled, ranging from non-insulin diabetics to normoglycemic individuals over a broad demographic. The primary outcome was the time in range (TIR), defined as a blood glucose of 54-140 mg/dL (54-180 mg/dL for diabetics).
Significant improvement in TIR was found for the entire study population, with the greatest benefit among those with a suboptimal baseline TIR. Surprisingly, those without a previous diagnosis of diabetes had the greatest improvement.
This study, although very short term and without a control group, is an important one, highlighting both the potential benefit of providing immediate and personalized feedback for blood sugar control among both normoglycemic and diabetic individuals, but also the frequency at which glucose dysregulation occurs even among those without diabetes.
Submit this form and you'll receive our latest news and updates.
Scientific Reports, one of the Nature journals, has recently published the results of a randomized clinical trial evalua...
Learn moreResults of the U.S. Diabetes Prevention Program (DPP) were first published in 2002 in the New England Journal of Medicin...
Learn moreAn analysis recently published in Cardiovascular Diabetology used a cluster-based approach to quantify the risk for deve...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
Proposition 65 Warning
© 2025 Biotics Research Corporation - All Rights Reserved
Submit your comment